Lauren Oliva, RPhAssociate Director, Global Regulatory Policy - New Technologies Policy Lead at Biogen
Lauren Oliva is the Global Regulatory Policy Lead for New Technologies at Biogen. She oversees the development and execution of R&D’s policy roadmap for digital health technologies and gene therapy to enable Biogen’s neuroscience portfolio. She is passionate about patient centric drug development & delivery and the impact of multi-stakeholder initiatives in advancing the adoption of new technologies through groups like Critical Path Institute and CTTI.
Lauren has over 10 years of experience in the pharmaceutical industry. In her time at Biogen she's held regulatory policy and strategy roles and launched a widely used regulatory intelligence platform. Lauren received her PharmD from Rutgers University, Ernest Mario School of Pharmacy and has previously served as adjunct faculty and lecturer at MCPHS University in Boston, MA.